Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
The Journal of Biological Chemistry
|
February 24, 2024
Triple-fusion protein (TriFu): A potent, targeted, enzyme-like inhibitor of all three complement activation pathways
Sophia J Sonnentag, Arthur Dopler, Katharina Kleiner, et al.
Journal of the American Heart Association
|
September 6, 2021
Predictors of Carotid Intima-Media Thickness Progression in Adolescents-The EVA-Tyrol Study
Sophia J Kiechl, Anna Staudt, Katharina Stock, et al.
BMC Cardiovascular Disorders
|
January 19, 2022
The association of allergic asthma and carotid intima-media thickness in adolescence: data of the prospective early vascular ageing (EVA)-Tyrol cohort study
Bernhard Winder, Sophia J Kiechl, Nadja M Gruber, et al.
European Journal of Nutrition
|
November 26, 2011
Prevalence of hypovitaminosis D and folate deficiency in healthy young female Austrian students in a health care profession
Stefan T Kaehler, Holger Baumgartner, Martina Jeske, et al.
Journal of Clinical Immunology
|
January 10, 2012
Activity of childhood lupus nephritis is linked to altered T cell and cytokine homeostasis
Monika Edelbauer, Sudhir Kshirsagar, Magdalena Riedl, et al.
Clinical Chemistry and Laboratory Medicine
|
February 8, 2021
Evaluation of four commercial, fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay
Christian Irsara, Alexander E Egger, Wolfgang Prokop, et al.
Immunobiology
|
January 22, 2016
Selectivity of C3-opsonin targeted complement inhibitors: A distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patients
Christoph Q Schmidt, Markus J Harder, Eva-Maria Nichols, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 17, 2022
Upregulation of Checkpoint Ligand Programmed Death-Ligand 1 in Patients with Paroxysmal Nocturnal Hemoglobinuria Explained by Proximal Complement Activation
Markus Anliker, Daniela Drees, Lorin Loacker, et al.
Microbiology Spectrum
|
October 12, 2022
One-Year Follow-Up of COVID-19 Patients Indicates Substantial Assay-Dependent Differences in the Kinetics of SARS-CoV-2 Antibodies
Alexander E Egger, Sabina Sahanic, Andreas Gleiss, et al.
Clinical Chemistry and Laboratory Medicine
|
April 10, 2021
Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers
Christian Irsara, Alexander E Egger, Wolfgang Prokop, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
The Journal of Biological Chemistry
|
February 24, 2024
Triple-fusion protein (TriFu): A potent, targeted, enzyme-like inhibitor of all three complement activation pathways
Sophia J Sonnentag, Arthur Dopler, Katharina Kleiner, et al.
Journal of the American Heart Association
|
September 6, 2021
Predictors of Carotid Intima-Media Thickness Progression in Adolescents-The EVA-Tyrol Study
Sophia J Kiechl, Anna Staudt, Katharina Stock, et al.
BMC Cardiovascular Disorders
|
January 19, 2022
The association of allergic asthma and carotid intima-media thickness in adolescence: data of the prospective early vascular ageing (EVA)-Tyrol cohort study
Bernhard Winder, Sophia J Kiechl, Nadja M Gruber, et al.
European Journal of Nutrition
|
November 26, 2011
Prevalence of hypovitaminosis D and folate deficiency in healthy young female Austrian students in a health care profession
Stefan T Kaehler, Holger Baumgartner, Martina Jeske, et al.
Journal of Clinical Immunology
|
January 10, 2012
Activity of childhood lupus nephritis is linked to altered T cell and cytokine homeostasis
Monika Edelbauer, Sudhir Kshirsagar, Magdalena Riedl, et al.
Clinical Chemistry and Laboratory Medicine
|
February 8, 2021
Evaluation of four commercial, fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay
Christian Irsara, Alexander E Egger, Wolfgang Prokop, et al.
Immunobiology
|
January 22, 2016
Selectivity of C3-opsonin targeted complement inhibitors: A distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patients
Christoph Q Schmidt, Markus J Harder, Eva-Maria Nichols, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 17, 2022
Upregulation of Checkpoint Ligand Programmed Death-Ligand 1 in Patients with Paroxysmal Nocturnal Hemoglobinuria Explained by Proximal Complement Activation
Markus Anliker, Daniela Drees, Lorin Loacker, et al.
Microbiology Spectrum
|
October 12, 2022
One-Year Follow-Up of COVID-19 Patients Indicates Substantial Assay-Dependent Differences in the Kinetics of SARS-CoV-2 Antibodies
Alexander E Egger, Sabina Sahanic, Andreas Gleiss, et al.
Clinical Chemistry and Laboratory Medicine
|
April 10, 2021
Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers
Christian Irsara, Alexander E Egger, Wolfgang Prokop, et al.
Page
of 4